 Kunihiko Suzuki, one of the leading pioneers in Japans emerging regenerative medicine industry, commits to a role as Senior Strategic Advisor to RepliCels Board of Directors VANCOUVER, BC ACCESSWIRE October 12, 2021 RepliCel Life Sciences Inc. OTC PINK:REPCFTSXV:RPFRA:P6P2 RepliCel or the Company, a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that Kunihiko Suzuki has agreed to accept an appointment as a Senior Strategic Advisor to its Board of Directors with a particular focus on building the Companys enterprise in Japan. We are delighted to have someone of Mr. 